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Summary 
The activation of CD8 + suppressor T  cells by normal intestinal  epithelial cells in antigen-spe- 
cific or allogeneic  mixed cell culture  systems has significant implications  for the regulation  of 
mucosal immune responses.  In this study, we found that the  capacity of epithehal  cells to in- 
duce  CD8 +  suppressor T  cell activation appeared to be linked  to the binding  of CD8  mole- 
cules on the T  cell surface. This appears to be mediated by a non-class I molecule expressed on 
the epithelial cell surface, which binds to CD8 and results in the activation of the CD8-associ- 
ated src-like tyrosine kinase, p56  lck. Epithehal cell-stimulated p56  lck activation is an early event 
(in  contrast  to  monocytes)  and  is  essential  for T  cell  activation,  since  proliferation  could  be 
completely abrogated by pretreatment of T  cells with genestein or herbamycin, both of which 
are protein tyrosine kinase inhibitors.  Pretreatment ofT cells with anti-CD8 or of intestinal ep- 
ithelial  cells with  an  anti-epithelial  cell mAb B9  inhibited  p56  lck activation  and further  con- 
firmed that CD8 on the T  cell and a CD8 ligand on the epithelial cell were involved in this T 
cell activation  event.  The  specificity of this reaction  was confirmed in  experiments  in which 
murine transfectants 3G4 and 3G8, expressing CD4  or CD8,  respectively, were used.  Cocul- 
ture  of 3G8  with  epithelial  cells  but  not  with  monocytes  activated  p56  lck  in  this  cell  line, 
whereas p56  lck was preferentially activated in 3G4 cells when monocytes were used as the stim- 
ulator cells. Although stimulation through  CD8- and CD8-associated p561ok was important for 
epithelial  cell-induced  T  cell  activation,  T  cell  proliferation  could  not be induced  by cross- 
linking CD8 alone with monoclonal antibody anti-CD8.  These data suggest that a second sig- 
nal, possibly through the T  cell antigen receptor since activation of the T  cell receptor-associ- 
ated kinase fyn was also seen, is required for epithelial cell-driven T  cell proliferation. 
O 
ver the  past several years, it has become increasingly 
apparent  that  the  rules  governing  mucosal  immune 
responses  differ from those  of the  peripheral  immune sys- 
tem.  First,  antigen  priming  via  the  oral  route  most  fre- 
quently  results  in  the  development  of immunologic  sup- 
pression or oral tolerance rather than in an active immune 
response.  Second,  the cell types in the gastrointestinal tract 
are  not  typical  of what  one  would  find  systemically.  In- 
traepithelial  lymphocytes are predominantly  CD8 +  T  cells 
that are,  in general,  anergic  despite exposure to inordinate 
numbers of disparate foreign antigens in the gut lumen  (1- 
3). In contrast, lamina propria T  cells are activated memory 
cells, a rich source of cytokines, but with limited prohfera- 
tive capacity to specific antigen  (4, 5). An understanding  of 
the underlying  mechanisms responsible for these phenom- 
ena has been slow to evolve, partly because of our limited 
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knowledge  of how the  primary trigger of an  immune  re- 
sponse,  antigen,  is handled  by the  gastrointestinal  mucosa. 
Our laboratory as well as others has focused on the role of 
the intestinal epithelial cell (IEC) 1 as an APC in this system. 
We  and  others  have  demonstrated  that  IEC  can  take  up, 
process,  and present soluble antigens  to primed T  cells  (6, 
7).  However,  unlike  conventional  APCs,  normal IEC ap- 
pear to  selectively activate  CD8 +  T  cells.  These  activated 
CD8 +  cells  express  suppressor  function  without  any  evi- 
dent  cytolytic  activity.  In  this  study,  we  define  a  mecha- 
nism whereby normal IEC can selectively activate CD8 + T 
cells.  By binding  and  cross-linking  CD8  on  T  cells  by  a 
non-class I ligand expressed on normal IEC, CD8 et chain- 
associated  p56 lck  is  activated.  This  activation  is  necessary 
but not sufficient for CD8 + T  cell proliferation. 
1Abbreviations  used in  this paper: CMF-HBSS,  calcium/magnesium-free 
HBSS; IEC, intestinal epithehal cell; PAS, protein  A-Sepharose; PKA, 
protein kinase A; PKC, protein kinase C. 
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Isolation of Peripheral Blood  T  Cells and Adherent Cells.  Heparin- 
ized venous blood was collected from normal donors, diluted l:3 
with sterile PBS,  layered on a  Ficoll-Hypaque (Pharmacia Bio- 
tech Inc., Piscataway, NJ) density gradient, and centrifuged for 30 
rain at 500 g (8). The mononuclear cells were collected from the 
interface  and washed  three  times  with  PBS.  Cells  were  resus- 
pended in P,  PMI  1640 (GIBCO BRL,  Gaithersburg, MD),  and 
the  cell density was adjusted to  5  X  106 cells/ml. T  cells  were 
separated using a rosetting technique with neuraminidase-treated 
sheep  red blood cells  and Ficoll-Hypaque density gradient cen- 
trifugation.  Non-T  cells  from  the  interface  were  collected, 
washed  three  times with PBS,  and resuspended in culture me- 
dium  (P,  PMI  1640,  10%  FCS,  50  lig/ml penicillin, 50  ;xg/ml 
streptomycin, and 2 mM glutamine; all from GIBCO BILL).  Ad- 
herent  cells  were  obtained by incubating non-T cells  in tissue 
culture dishes (25 million cells per dish in 10 ml culture medium 
for 45 min at 37~  in a humidified 5% CO2 incubator). B  cell- 
enriched nonadherent cells were then aspirated, and dishes were 
washed  vigorously three  times  with  PBS.  Adherent  cells  were 
harvested by scraping cells offusing a rubber policeman. Rosetted 
T  cells  were treated with 0.75% ammonium chloride on ice for 
5-10 min to lyse sheep red blood cells. The T cell suspension was 
then washed three times with PBS and was finally resuspended in 
culture medium. Small numbers of contaminating adherent cells 
in the T  cell suspension were removed by the adherence proce- 
dure described above. The purity of isolated T  cell preparations 
was assessed by staining. Typical preparations were >95% CD3 +, 
<1% CD14 +, and <1% slg  +. 
Preparation of Human  IEC.  The procedure used for the isola- 
tion of IEC is a modification of the method used by D. M. Bull 
and M.  A. Bookman for the isolation of lamina propria and in- 
traepithelial lymphocytes (9). 1Kesected tissue specimens removed 
from patients with colon cancer at least 10 cm away from the car- 
cinoma  (histologically  normal)  were  washed  extensively  with 
HBSS (GIBCO BR.L) containing 50 lig/ml penicillin, 50 p,g/nfl 
streptomycin,  50  p~g/ml  gentamicin (Sigma  Chemical  Co.,  St. 
Louis, MO), and 2.5 p,g/ml amphotericin B  (Flow Laboratories, 
Inc., McLean, VA). The surface mucosa was stripped off from the 
underlying submucosa and minced into tiny pieces.  These were 
placed in calcium/magnesium-free HBSS (CMF-HBSS) contain- 
ing antibiotics and  1 mM  dithiothreitol  (Sigma Chemical Co.) 
and incubated in a 37~  water bath for 5 min to remove adherent 
mucus. The tissue pieces were washed again in CMF-HBSS and 
incubated in  1KPMI  1640  containing 3  mg/ml  dispase  (Boeh- 
ringer Mannheim Corp.,  Indianapolis, IN) in a 37~  water bath 
for 30 rain, vortexing every 5 rain. During this treatment, epithe- 
lial cells  and intraepithelial lymphocytes were  released from the 
tissue. Cells that remained loosely adherent to the tissue were re- 
covered  using a  rubber  policeman.  Dispase  treatment  was  re- 
peated  once.  Isolated  epithelial  cells  were  washed  twice  with 
CMF-HBSS  and  then  applied  to  Ficoll-Hypaque  and  Percoll 
density gradients to improve the viability and purity of the prepa- 
ration. The purified epithelial cells were >95% viable, <0.1% es- 
terase  positive,  <0.l%  OKM1 +,  <0.1%  OKT6  +,  <1%  surface 
Ig  +, and l-2% CD3 §  Cells were usually irradiated 3,000 rad and 
kept in RPMI 1640 containing 5% human agammaglobulinemic 
serum. 
Murine Transfectants 3G4 and  3G8.  The murine transfectants 
3G4 and 3G8, expressing human CD4 and CD8 antigens, respec- 
tively, were kind gifts from Dr. S.J. Burakoff (Dana-Farber Insti- 
tute, Boston, MA). The construction of these hybridoma trans- 
fectants has been previously described. For construction of the 3G4 
cell  line (10),  the  T  cell hybridoma BY155.16  was  transfected 
with the defective retrovims MNST4 carrying human CD4 cDNA, 
and transfectants expressing human CD4 antigen were selected by 
sorting. The establishment of the 3G8 cell line was similar, tram- 
fecting the  T  cell hybridoma BY155.16  with the  retroviral ex- 
pression vector MNCT8 carrying human CD8a cDNA (11). 
mAbs.  OKT8 (anti-CDS) and W6/32 (anti-HLA class 1) were 
obtained from  American  Type  Culture  Collection  (Rockville, 
MD).  Both have previously been shown to inhibit human CTL 
activity. VG2  (anti-class II monomorphic determinant) was the 
kind gift of Dr. Shu Man Fu (University of Virginia, Charlottes- 
ville, VA). FFB 2.3 (anti-CD4) was a gift from Dr. David Posnett 
(New York Hospital, New York), and mAb 446 (anti-CI)3) has 
been previously defined in this laboratory (12). mAbs B9 and L12 
against human IEC  membrane antigens were  generated  in our 
laboratory as  previously described  (13).  These  two  mAbs were 
chosen for their ability to specifically inhibit IEC-driven CI)8 + T 
cell proliferation. 
lmmunoprecipitation  and In  Vitro Tyrosine Kinase Assay.  Isolated 
peripheral blood  T  cells  were  incubated in an  Eppendorf tube 
with either normal IEC, peripheral adherent cells  (10 million T 
cells:10 million stimulator cells),  or antibodies cross-linking C1)4 
or CD8 in a 37~  water bath for varying time periods. At specific 
time points, the tube was transferred to ice and cold 2￿  NP-40 
lysis  buffer  (2%  NP-40,  40  mM  Tris  base,  pH  8.0,  300  mM 
NaCI, 400 p,M EDTA, 20 mM sodium pyrophosphate, 200 mM 
sodium fluoride, 1 mM PMSF, 5 n~M iodoacetamide, 20 lig/ml 
aprotinin, 20  btg/ml leupeptin,  and  200  b~M  Na3VO4)  (Sigmaa 
Chemical Co.)  was  added  for 30  min, vortexing every  5  rain. 
The  lysate was  centrifuged at  14,000  rpm  for  10  rain ill a  mi- 
crofuge  to  remove  cell  debris.  The  lysate  was  then  precleared 
with protein A-Sepharose (PAS; Phamlacia Biotech, Inc., Piscat- 
away, NJ)  (30 ILl of a 50% PAS bead suspension per sample) fi3r 
30  min at  4~  The  clarified lysate  was  incubated with  4G10 
(antiphosphotyrosme  mAb)  (Upstate  Biotechnology,  Inc.,  Lake 
Placid,  NY)  (5  lig per sample),  anti-lck sera  (gift  of Dr.  C.  E. 
Rudd, Dana Farber, Boston, MA), or anti-fyn (Upstate Biotech- 
nology, Inc.) for l  h  at 4~  in the presence of PAS (50 bd of a 
50% PAS bead suspension per sample) and incubated for 2  h  at 
4~  The  immunoprecipitates  were  washed  once  with  PBS, 
twice with 0.5 M  LiC1 (Sigma Chemical Co.) in 20 mM Tris, pH 
8.0,  and once with kinase buffer (10 mM  MnCI2, 50 mM Tris, 
pH 7.4). The inwnunoprecipitates were finally resuspended in ki- 
nase buffer (30 txl per sample) and mixed with y-[32p]ATP (Am- 
ersham Corp., Arlington Heights, IL) (10 p,  Ci per sample). After 
an incubation of 30 min at 25~  the reaction mixture was sub- 
jected to 10% SDS-PAGE and autoradiography. 
For mAb blocking studies, we incubated T  cells with OKT8 
(Ortho Diagnostic Systems, Inc., P.aritan, NJ) (10 llg/ml) or nor- 
mal IEC with the anti-epithelial cell mAbs B9 (10 b~g/ml) or L12 
(10  ;Ig/ml)  at  4~  for  30  min.  Unbound antibodies were  re- 
moved by washing. Treated or untreated T  cells were then incu- 
bated with treated or untreated normal epithelial cells at 37~  for 
2 min. Ceils were lysed, and p56  lck enzyme activity was measured 
as described above. 
Western  Blot with Antiphosphotyrosine  mAbs.  Lysates  were  re- 
solved on 7.5% SDS-PAGE and transferred onto a nitrocellulose 
membrane at  15  V  overnight in transfer buffer (20% methanol, 
150 m_M glycine, 25  mM Tris, pH  8.3).  The transfer sandwich 
was prewetted in transfer buffer and set up in the following order: 
(a) a porous polyethylene foam sheet; (b) one sheet of 3-M filter 
paper;  (c)  the gel; (d)  a nitrocellulose membrane sheet  (0.2  lira) 
(Schleicher &  Schuell,  Inc., Keene, NH);  (e)  another sheet  of 
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foam.  The transfer sandwich was inserted into a transfer electro- 
phoresis unit with the nitrocellulose membrane at the anode. Af- 
ter transfer, the nitrocellulose sheet was blocked by 50 ml of 5% 
nonfat milk in PBS.  The  nitrocellulose sheet was  washed  once 
with  PBS  and transferred to  another plastic  bag containing the 
antiphosphotyrosine  antibody  (4G10;  Upstate  Biotechnology 
Inc.) (1  p~g/ml)  in a 0.5% nonfat milk-PBS solution. The plastic 
bag was  then sealed,  and the  sheet in the  bag was  incubated at 
room  temperature  for  2  h  or  4~  overnight.  The  sheet  was 
washed five times with washing buffer (0.05% Tween 20 in PBS), 
for  5  rain each  time,  and then transferred to  a  new plastic bag 
containing the secondary antibody (goat anti-mouse IgG), which 
had  been conjugated with  horseradish peroxidase  (1-2  p,g/ml). 
The  incubation was  continued at room  temperature for  1-2  h. 
The sheet was washed five times with washing buffer, 5-10 nfin 
each  time, and incubated with  12  ml of chemiluminescence re- 
agent  (DuPont,  Wilmington, DE)  at  room  temperature  for  1 
rain. A  sheet of plastic wrap was  placed onto the nitrocellulose 
sheet,  and the  sheet was  exposed  and developed  (XAR-5  film; 
Eastman Kodak Co., Rochester, NY). 
Mixed  Cell  Culture  Responses  in  the  Presence  of  Blocking 
rnAbs.  An allogeneic mixed cell culture reaction was performed 
as previously described (6) using 105 irradiated IEC as stimulators 
and l0  s allogeneic isolated T  cells  in the presence of mAb anti- 
CD4,  anti-CDS,  anti-class I,  anti-class II,  or an irrelevant iso- 
type--matched Ab  control  (25  txg/ml for  each  mAb)  in culture 
medium.  All  cultures  were  performed  in  triplicate  in  96-well 
round-bottomed microwell plates for 120 h  at 37~  in a 5% CO2 
humidified incubator.  During the  last  18  h  of culture,  l  ~Ci 
[3H]thymidine  (ICN  Biomedicals,  Inc.,  Costa  Mesa,  CA)  was 
added,  and  cells were  harvested  onto  glass  fiber filter mats  for 
counting. Counts were  obtained and averaged by a  scintillation 
counter  (model LS3801;  Beckman Instruments, Inc.,  Somerset, 
NJ). 
Inhibition of T Cell Proliferation in the Presence  of  Kinase Inhibitors.  10  s 
adherent cell-depleted T  cells  used as responder cells were  cul- 
tured  with  10  s  irradiated  (3,000  rad)  human  IECs  or adherent 
cells as stimulators in 200  ~1 culture medium, in the presence or 
absence of 200 ~M genestein (Calbiochem-Novabiochem Corp., 
La Jolla, CA) added at time 0 or 2 h after the onset of culture. In 
all experiments, one set of T  cells was pretreated with genestein 
(200 ~M) for 2  h  followed by removal of genestein by washing. 
The treated T  cells were then added to cultures containing irradi- 
ated  IECs  or  monocytes.  In  other  experiments,  inhibition by 
genestein was  compared with  either herbamycin (a  specific  ty- 
rosine kinase inhibitor; 0.45-1.8  ~M),  staurosporine  (a protein 
kinase C  [PKC]  inhibitor; 5  nM),  and H-8  (a protein kinase A 
[PKA] inhibitor; 5 t~M).  All cultures were performed in triplicate 
in 96-well round-bottomed microtiter plates (Becton Dickinson 
Labware, Franklin Lakes,  NJ) for 120 h at 37~  in a 5% CO2 hu- 
midified  incubator,  and  proliferation  was  assessed  as  described 
above. 
Results 
Binding  to  CD8  on  T  Cells Is Required for Normal IEC-in- 
duced  CD8 +  Suppressor  T  Cell  Proliferation.  We  have pre- 
viously  demonstrated  that  freshly  isolated  normal  human 
IECs were able to trigger CD8 +  suppressor T  cell prolifer- 
ation  in  a  mixed  cell  culture  system  (6).  However,  the 
mechanism of the  generation of these  antigen-nonspecific 
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Figure  1.  Inhibition of epithelial cell-stimulated  peripheral  blood T 
cell proliferation by specific mAbs. Freshly isolated IECs (105/well) were 
cultured with peripheral blood T cells at a ratio of 1:1 in triplicate cultures 
in 96-well U-bottomed plates in the presence or absence of either/nAb 
anti-CD4, anti-CD8, anti-class  I,  anti--class II, or  an isotype-matched 
control mAb at 25 Ixg/rnl for 120 h. [3H]Thymidine (1 I.tCi) was added 
18 h before harvest, and thymidine incorporation was measured. This ex- 
periment is representative of at least 10 experiments. The anti-CD8 mAb 
OKT8 failed to inhibit PHA-induced proliferation of these same periph- 
eral blood T cells (86,143 vs 85,459 cpm). 
CD8 +  suppressor  T  ceils was  not  addressed.  To  examine 
the role of specific surface molecules involved in this T  cell 
activation event, we cultured T  cells with varying concen- 
trations of either  anti-CD4,  anti-CD8,  anti-class I  MHC, 
or anti-class II MHC  mAbs. As previously reported,  mAbs 
against CD4 have the capacity to inhibit CD4 + T  cell acti- 
vation  and  proliferation  (14).  Thus,  by  adding  anti-CD4 
mAbs, we would be able to highlight any T-T  interaction. 
As seen in Fig.  1, antibodies to CD4 failed to inhibit CD8 + 
T  cell proliferation induced by IECs at any concentration. 
However,  CD8 + T  cell proliferation could be inhibited by 
anti-CD8  mAbs,  suggesting that  the  CD8  molecule  itself 
may be  involved directly in this process.  Of note was  the 
finding that  the  same  anti-CD8  mAb  failed to  inhibit the 
proliferation of isolated  CD8 +  T  cells to  PHA  (see Fig.  1 
legend),  suggesting  that  the  effects  seen  with  this  mAb 
were  directed  at  the  interaction  of epithelial  cells  and  T 
Figure 2,  Determination of p56  l'k enzyme activity in activated periph- 
eral blood T cells using an in vitro kinase assay. Peripheral blood T cells 
(10 ￿  106 cells each) stimulated with either anti-CD4 mAb (cross-linked 
with rabbit anti-mouse IgG for 1 rain), normal human IECs, or mono- 
cytes (for 2 rain) were lysed, immunoprecipitated  with an anti-lck anti- 
body, and autophosphorylated in the presence of~/-[32p]ATP. Total reac- 
tants were  analyzed on 10% SDS-PAGE  and exposed on film. Lane  I, 
unstimulated T cells; lane 2, cross-linked anti-CD4-activated T cells; lane 
3, enterocyte-activated T cells; lane 4, monocyte-activated T cells; lane 5, 
enterocytes only; and lane 6, monocytes only. Figure 3.  Analysis  of T cell surface molecules responsible for p56  ~ck ac- 
tivation induced by IECs. (A) Murine T cell hybridomas transfected with 
human CD4 or CD8 cDNA (3G4 and 3G8, respectively)  were used as re- 
sponder cells in coculture with human IECs or with anti-CD4  or anti- 
CD8 mAbs  as a positive control. The level of p56  Ick enzyme activity was 
measured in an in vitro protein  tyrosine kinase assay. The position of 
cells and were not due to nonspecific suppression ofCD8 + 
T  cells. Furthermore, this anti-CD8 mAb (OKT8) has been 
previously shown  to  inhibit  CTL  activity  (15).  Interest- 
ingly, an  mAb against a  framework  determinant of class I 
(W6/32),  the  conventional ligand for  CD8,  failed to  in- 
hibit T  cell proliferation. In fact,  the  pattern  of prolifera- 
tion was  comparable to  that seen with  anti-CD4.  Similar 
to  anti-CD8,  W6/32  has been shown  to  inhibit CTL  ac- 
tivity (16). 
In contrast,  the anti-class II mAb, VG2,  was  capable of 
inhibiting T  cell proliferation comparable to that seen with 
anti-CD8. Since T  cell activation can be inhibited by anti- 
class II Abs present in the culture wells (17), we pretreated 
the  epithelial cells with the  anti-class II mAb VG2 for 30 
min  at 4~  washed them  free  of unbound  antibody, and 
used  them  as  stimulators  in  MLR  cultures  with  isolated 
CD4 +  or  CD8 +  T  cells  as  responder  cells.  Pretreatment 
with class II mAbs resulted in the inhibition of CD4 +  but 
not CD8 + T  cell proliferation (data not shown). These data 
suggest  that  our  initial  findings  relating  to  inhibition  of 
proliferation in  allogeneic IEC:T  cell cultures by  a  poly- 
clonal anti-class II antibody (6) were due to direct inhibi- 
tion of T  cell activation by this antibody. Furthermore, the 
finding that IEC-driven CD8 +  T  cell proliferation persists 
even  in  the  presence  of anti-CD4,  anti-class I,  and  anti- 
class  II  mAbs  provides  support  for  an  alternate  pathway, 
potentially a  novel ligand for CD8,  that may be activating 
these  cells.  The  increase  in 3H  incorporation  seen  in  the 
anti-CD4 and anti-class I mAb-treated cultures was repro- 
ducible in all experiments and may represent freer access of 
CD8 to a novel ligand. 
Both  Normal IECs and Monocytes Induce the Activation of 
p56  l'k.  Recent findings indicate that CD4  and CD8 mol- 
ecules serve not only to enhance the weaker binding of the 
T  cell receptor to the MHC-Ag  complex on APCs but also 
to transduce signals themselves to  T  cells through binding 
to their respective ligands. Although CD4 and CD8 intrin- 
sically do not possess kinase activity, their intracytoplasmic 
tails are physically associated with  the  src-like protein ty- 
rosine kinase, p56  lck (18,  19).  Cross-linking CD4  or CD8 
by monoclonal antibodies has been shown to induce p56  lck 
activation. In a representative experiment shown in Fig. 2, 
we investigated the activation of p56  lck protein tyrosine ki- 
nase  activity after  culturing T  cells with  normal  IECs  or 
monocytes for 2  rain. Under reducing conditions, the un- 
stimulated T  cell lane shows the basal level of p56  lck activ- 
ity. Cross-linking CD4  with anti-CD4 mAb,  culture with 
normal [ECs,  or monocytes results in a marked increase in 
p561ok enzyme  activity.  No  detectable p56  lc~  activity was 
seen  in  the  stimulator  cells  alone,  i.e.,  normal  epithelial 
cells or monocytes. These studies imply that, during cocul- 
p561ok is depicted by the arrow. (B) Murine transfectants 3G4 and 3(;8 
were stimulated by monocytes or with the appropriate mAb (anti-CD4 or 
anti-CD8,  respectively) as positive controls, and the activation of p56  t'k 
was determined. 
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p56  kk is triggered and activated as an early event. 
The Pathway of Activation  of p56  kk Induced by Normal Epi- 
thelial Cells  and  Monocytes  is  through  CD8  and  CD4  Mole- 
cules,  Respectively.  Although  stimulation  through  either 
CD4  or CD8  molecules  can  activate  p56  l~k, other  surface 
molecules  (e.g.,  IL-2R, CD2)  have been reported to have 
the capacity to activate, or to be associated with the activa- 
tion of, p56  lck (20-21).  To assess the specific molecules in- 
volved in a p56  lck activation by normal epithelial  cells and 
monocytes, we used  two transfected murine  T  cell hybri- 
domas expressing either human CD4 (3G4)  or CD8 (3G8) 
molecules.  3G4  and  3G8  cell  lines  were  cocultured  with 
normal epithelial cells or monocytes, and p56  lck enzyme ac- 
tivity was measured. From Fig. 3 A, one can clearly see that 
normal  epithelial  cells  activate  p56  lck in  the  3G8  cell  hne 
Figure 4.  Antiphosphotyrosine  Western blot oflysates  from (A) normal 
IEC:3G4/3G8 or (B) the epithelial cell line DLD-I:3G4/3G8 cocultures. 
3G4 or 3G8 cells were cocultured with equivalent numbers of  freshly iso- 
lated normal IEC (A) or DLD-1 cells for varying time periods, lysed, and 
resolved on 7.5% SDS-PAGE.  The gel was transferred onto nitrocellulose 
and  subjected to  Western blot  analysis using the  antiphosphotyrosine 
mAb 4G10 as described in Materials and Methods. These blots are repre- 
sentative of at least five experiments. 
but not in the 3G4 cell line. In contrast, monocytes activate 
p56  lck in  3G4  cells  (Fig.  3  B).  While  3G8  appears  to  be 
more  vigorous  in  its  response  to  any  stimulus  (mAb  or 
IEC),  probably both  because  of the  greater  expression  of 
CD8  on 3G8  than  of CD4 on 3G4  and the  formation of 
CD8e~/e~  homodimers,  the  difference  in using monocytes 
vs IEC as stimulator  cells is  clear.  In the  case of epithelial 
cell  stimulation,  there  was  no  detectable  up-regulation  of 
p56  lck  enzyme activity in  3G4  cells  when  compared with 
the unstimulated  background control, whereas a  >  10-fold 
increase  in  p56  kk  enzyme activity was  seen  in  3G8  cells. 
Monocytes stimulated  p56  kk enzyme activity in  3G4  cells 
to a much greater extent than in 3G8 cells,  especially since 
the background p561ok activation in the 3G8 cells was com- 
parable to the monocyte-stimulated activity. Since the only 
human  surface  molecules  expressed  on  these  transfectants 
were  either  CD4  or CD8,  these  data support  the  concept 
that IEC express a molecule (non-class I) that binds to CD8 
to activate p56  l~k. 
To determine whether activation of p56  l~k was selective 
or  part  of a  global  activation  of intracellular  kinases,  we 
performed  similar  cocultures  (IEC and  3G4  or 3G8  cells) 
but analyzed tyrosine phosphorylation by Western blot us- 
ing  the  antiphosphotyrosine  mAb  4G10.  Increased  phos- 
phorylation of a  56-kD  band was seen at 30 s in the 3G8 
but  not  in  the  3G4  cells  as  described  above,  peaked  at  2 
rain,  and returned  to baseline  at  10 rain  (Fig.  4  A).  Con- 
comitantly,  there  was  tyrosine  phosphorylation  of sub- 
strates at 72 and 86 kD with similar kinetics.  Given the au- 
tophosphorylation of p56  lck seen in the kinase  assays,  these 
higher molecular weight bands appear to be lck substrates. 
No  other  phosphorylated  proteins  were  seen  in  the  3G4 
cells.  Similar results were obtained by coculturing the ma- 
lignant IEC line DLD-1 with 3G4 and 3G8 cells, although 
a  greater  number  of phosphorylated  bands  were  detected 
(Fig. 4  B). However, some of these substrates  appear to be 
derived  from  the  epithelial  cell  line  itself,  as  many  were 
seen at the onset of culture (time 0). 
Activation  of p56  zck Occurs Early and Is Critical  for CD8  + T 
Cell Proliferation.  To determine the kinetics of p56  kk acti- 
vation,  normal IECs were incubated with T  cells for vari- 
able  time  periods  and lysed,  and p56  lck activity was  mea- 
sured.  In Fig. 5 A, epithelial cell-stimulated p56  lck activation 
could be seen maximally at 1 min, persisted for 5 rain,  and 
declined  at  10  rain.  After 30  min,  the  enzyme activity of 
p56  kk  was  nearly  baseline.  In  contrast  to  epithelial  cells, 
monocyte-stimulated  T  cell-associated  p56  l~k  activity  in- 
creased  gradually,  reaching  a  maximum  at  N30  min  and 
maintaining  the  activated  state  for  up  to  2  h  (Fig.  5  B). 
These  differences in the kinetics  of p56  lck enzyme activity 
induced by normal IECs versus monocytes may reflect the 
different functional requirements  of p56  kk in the activation 
of different T  cell populations. 
Genestein  and  Herbamycin,  Tyrosine  Kinase  Inhibitors,  In- 
hibit Both Normal Epithelial Cell- and Monocyte-stimulated Pe- 
ripheral Blood  T  Cell  Proliferation.  To  test  whether  p56  kk 
activation is critical for CD8 + T  cell proliferation,  we cul- 
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presence of varying concentrations of genestein,  a tyrosine 
kinase inhibitor.  Since the kinetics  of p56  lck activation was 
different depending upon the nature of the stimulator cells, 
we added genestein early (2 h  before culture),  at the onset 
of culture,  or  2  d  after  culture.  Preincubation  of T  cells 
with genestein for 2 h  resulted in complete inhibition of T 
cell  proliferation  induced by enterocytes  (Fig.  6  A), while 
genestein  added at the onset of culture  of T  cells  and epi- 
thelial  cells  resulted in only 50% inhibition.  No inhibition 
of T  cell proliferation was seen when genestein was added 
2  d  after the onset of culture,  suggesting that inhibition  of 
an early event was critical (data not shown), and genestein's 
effects were not mediated via nonspecific toxicity.  In con- 
trast, monocyte stimulation ofT  cells  was inhibited regard- 
less  of when  genestein  was  added,  consistent  with  the 
kinetics  data  (Fig.  6  /3). Preincubation  of T  cells  with 
genestein  allows  for the  complete  inhibition  of intracyto- 
plasmic  tyrosine  kinase  before  coculture  with  stimulator 
cells.  This inhibition  of an  early response to epithelial  cell 
stimulation  indicates that the initial  tyrosine kinase  activa- 
tion is critical for normal epithelial  cell-driven T  cell pro- 
liferation. Activation of tyrosine kinases is also important in 
monocyte-driven T  cell proliferation but appears to require 
both  early  and  ongoing  events.  Therefore,  the  pathways 
promoting T  cell proliferation  used by normal  epithelium 
and monocytes appear to be different.  Since genestein may 
not be  a  specific  tyrosine  kinase  inhibitor,  we  confirmed 
these data comparing the effects of herbamycin, a selective 
tyrosine kinase  inhibitor,  with  the  effects of staurosporine 
(a PKC inhibitor)  (5 nM) or H8 (a PKA inhibitor)  (5 Ixm). 
As seen in Fig. 6  C, herbamycin (at varying concentrations) 
but not staurosporine  or H8 added at the  onset of culture 
inhibited  IEC-driven  T  cell  proliferation.  These  findings 
support the concept that the activation of a tyrosine kinase 
is critical to the T  cell proliferation induced by IEC. 
The Activation of CD8 /p56  l~k Is Necessary but Not Suflkient 
for Normal IEC-driven  T  Cell Proliferation.  Given the find- 
ings  described  above,  we  wanted  to  determine  whether 
stimulation  through  CD8  alone  was  sufficient  to  drive  T 
cell proliferation.  In these experiments, we cultured PBMC 
with  mAb OKT8,  446  (anti-CD3),  L12 (IgG1 here acting 
as a  negative control),  or PHA in the presence or absence 
of IL-2 for 2 d. mAb 446 (anti-CD3)  was able to stimulate 
T  cell proliferation in the absence of IL-2 (data not shown). 
In contrast, mAb OKT8 (anti-CD8)  could not stimulate T 
cell proliferation even in the presence oflL-2 and accessory 
cells,  despite the fact that p56  jck activation was seen (Fig. 2). 
These  results  indicate  that  signals  through  CD8  alone  are 
not  sufficient  to  drive  T  cell  proliferation,  and  they  raise 
the possibility of the requirement for a second signal. 
Figure 5.  Time course of tyrosine autophosphorylation  of p56  lck acti- 
vated by IECs (A) and monocytes (B). Peripheral blood T cells were co- 
cultured with epithelial cells (A) or monocytes (B) for varying time peri- 
ods. The reaction was stopped by adding cold 2￿  lysis buffer. The lysate 
was imnmnoprecipitated with anti-lck antibody, and p56  kt tyrosine ki- 
nase activity  was then measured in an in vitro tyrosine kinase assay. Cross- 
linking with anti-CD4 or anti-CD8 served as positive controls. The ar- 
row depicts p56  kk. 
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cocultures. Cocultures were established  as described  in Figs. 2 and 5 ex- 
cept that anti-fyn was used as the immunoprecipitating mAb. For alloge- 
neic IEC:T cell cocultures, the reaction was stopped at 2 rain and com- 
pared with the response seen using the anti-CD3 mAb OKT3.  In the T 
cell:non-T cell cocultures, the reaction was stopped at 2,  10, and 25 rain. 
Both coculture conditions result  in the phosphorylation of fyn, although 
the kinetics  is different. 
Figure 6.  Inhibition oflEC-stimulated T  cell proliferation in the pres- 
ence of the protein tyrosine kinase  inhibitors genestein and herbamycin. 
(A) T  cells treated or untreated with genestein (200  p.M) 2 h before or at 
the  onset  of  culture  were  incubated  with  irradiated  IECs  for  5  d. 
[3H]Thymidine was added 18 h before cell harvesting, and thymidine in- 
corporation was measured in a scintillation  counter. (/3) T  cells treated  or 
untreated with genestein (200/~M) 2 h before, at time 0, or 2 d after the 
onset of culture were incubated with irradiated  monocytes for 5 d,  and 
[3H]thymidine incorporation was measured. Viability  was comparable in 
treated  and  untreated  cultures on  day  5  before harvesting.  (C)  T  cells 
were cocultured with normal IEC in the presence or absence of herba- 
mycin (0.45-1.8 Ixm), staurosporine (5 riM), or H8 (5 m/Vl) for 5 d as de- 
scribed above. Neither herbamycin (at any concentration), staurosporine, 
or H8 had any inhibitory effect  on T  cells stimulated with PHA  (T  + 
PHA =  44,780  cpm; T  +  PHA +  0.45  ~m herbamycin =  56,443  cpm; 
T  +  PHA  +  1.8  p,M  herbamycin =  54,398  cpm; T  +  PHA  +  5 nM 
staurosporine =  42,408  cpm; T  +  PHA  +  5  I~M H8  =  38,077  cpm). 
These findings  are representative of two experiments. 
Given the system used to induce  CD8 + T  cell prolifera- 
tion  (allogeneic  cells  or  Ag-pulsed  autologous  IEC),  the 
second  signal  may be mediated  through  the  T  cell Ag re- 
ceptor.  To address this possibility more directly, we cocul- 
tured  allogeneic  IEC with  nylon wool-purified  T  cells for 
2  rain,  lysed the ceils,  immunoprecipitated  the TCk-asso- 
ciated  kinase  fyn,  and  performed  an  in  vitro  kinase  assay. 
These  studies  could  not  be  performed  with  the  murine 
transfectants  since  their  Ag  receptors  would  not  be  ex- 
pected to  recognize  human  alloantigens.  As seen  in  Fig.  7 
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A, fyn kinase activity was increased  after T  cell:IEC cocul- 
ture.  Monocytes were also able to activate fyn kinase activ- 
ity but  with  different  kinetics  (peaking at  25  min)  (Fig.  7 
/3). Since  p56  lck is not  known  to phosphorylate  fyn,  these 
findings suggest an independent  coactivation step involving 
the TCR. 
The Activation of  p56  I~k Induced by Normal Epithelial Cells Is 
Blocked by mAb Anti-CD8 and B9.  Since mAb anti-CD8 
could block epithelial cell--stimulated CD8 + T  cell prolifer- 
ation  while  mAbs  to  class  I,  the  conventional  tigand  for 
CDS,  could  not,  we used  anti-epithelial  cell mAbs to  de- 
fine the ligand for CD8  expressed on epithelial cells, mAbs 
B9 and L12 were selected for their ability to inhibit normal 
epithelial,  cell  induced  CD8 +  T  cell  proliferation  when 
present  in  the  culture  (13).  B9  stains  intestinal  epithelium 
from  all  sites  (except  for esophageal  epithelium)  with  vil- 
lus>crypt  staining,  and  it  fails  to  stain  T  cells,  B  cells,  or 
monocytes.  L12 stains intestinal  epithelium  more intensely 
than  B9  and  also  fails  to  stain  PBMC.  To  determine 
whether  the  activation  of p56  lck in  CD8 §  T  cells induced 
by normal epithelial cells occurs via the binding of a  novel 
CD8 ligand on epithelial  ceils to CD8  on T  cells, we used 
mAb  OKT8  and  anti-epithelial  cell  mAbs B9  and  L12  to 
block  p56  kk  activation.  Fig.  8  shows  that  OKT8  and  B9 
can inhibit  p56  Ick activation,  while  L12 generally does not. 
These  findings  suggest  that  mAb  B9  might  recognize  a 
ligand  for CD8  on  the  epithelial  cell  surface  or at least be 
situated near such a ligand,  mAbs to CDld,  which we have 
previously  demonstrated  to  be  inhibitory  for proliferation 
in  T  cell:IEC  cocultures,  failed inhibit  activation  of CD8- Figure  8.  Inhibition of IEC-induced p50  ~k  activation in  peripheral 
blood T cells by mAbs. IECs were treated with inAb B9 or L12, or T 
cells were treated with mAb OKT8 (anti-CD8), for 30 rain at 4~  and 
unbound antibodies were removed by washing. Treated or untreated epi- 
thehal cells were cocultured with treated or untreated T ceils, and the in- 
duction of  p561ok enzymatic  activity  immunoprecipitated by anti-lck anti- 
body was measured in an in vitro tyrosine kinase assay as described in 
Figs. 2 and 5. 
associated p56  lck, suggesting that this molecule does not as- 
sociate with CD8 (data not shown). 
Discussion 
The fact that oral tolerance can be mediated via the gen- 
eration  of T  suppressor  cells  is  well  established  (22,  23). 
The  mechanism  of activation  of such  cells  is  still  not de- 
fined.  In this study, we demonstrate  that CD8 + suppressor 
T  cells  activated  by  normal  IEC  require  binding  to  the 
CD8 molecule itsels  In this setting,  crossqinking CD8 ac- 
tivates  the  src-like  tyrosine  kinase,  p56  kk.  This,  in  turn, 
may phosphorylate a number of substrates,  resulting in nu- 
clear  signaling  for cell  proliferation.  Positive  activation  of 
cells through CD8 contrasts with studies by van Seventer et 
al.  (15),  who  reported  that  anti-CD8  mAbs could inhibit 
cytotoxicity of CTL clones.  Although we have not found 
anti-CD8 mAbs to be inhibitory to CD8 + T  cell prolifera- 
tion induced by mitogens, the results from van Seventer et 
al.  are not incongruent with ours.  First,  we are analyzing a 
distinct phenomenon, suppressor T  cell activation. Second, 
we  are  dealing  with  a  ligand  for CD8  expressed  on  IEC 
that is not class  I, since anti-class  I  mAb treatment  of IEC 
failed to inhibit CD8 §  T  cell proliferation while it can in- 
hibit  CTL activity (16).  In addition,  class  I  alone does not 
appear  to  be  capable  of activating  CD8-associated  p56  kk, 
and coculture of 3G4 or 3G8 cells  with the thyroid epithe- 
lial  cell line LA-t  expressing class  I at levels comparable to 
normal  IEC  (but failing to  express  B9  or L12)  fails  to in- 
duce  tyrosine  phosphorylation  in  either  cell  type.  Third, 
recent studies suggest that the inhibitory effect mediated by 
soluble  anti-CD4  or anti-CD8  interferes  with  coreceptor 
formation with the TCR-CD3  complex (24-26).  Further- 
more,  we are not dealing with  a  T  cell-T cell  interaction 
(CD4-CD8),  since  antibodies  to  CD4  also  fail  to  inhibit 
CD8 +  T  cell  proliferation.  In  fact,  an  interesting  finding 
that is  consistently observed is  the  enhancement  of CD8 + 
T  cell proliferation  in the presence of anti-CD4  and anti- 
class  I  mAbs. This may relate to the enhanced accessibility 
of CD8  molecules  for a  non-class  I  ligand  (in  the  case of 
anti-class  I), promoting a greater response in the  CD8 +  T 
cells.  In the setting ofanti-CD4 treatment,  there may be an 
increase in the ability ofCD8 + rather than CD4 § T  cells to 
interact  with  IEC.  Regardless,  the  end  result  is  a  positive 
growth signal transmitted to CD8 + cells. 
The nature of  the positive signal to CD8 + T  cells appears 
to be the activation of p56  lck. Several laboratories  have de- 
scribed  an  src-like  tyrosine  kinase,  p56  kk,  associated  with 
the intracytoplasmic tail of CD4 and the CD8cl chain  (18- 
19).  Cross-linking of these molecules with antibody results 
in induction of kinase activity with autophosphorylation as 
well as phosphorylation of a number of associated substrates 
that modulate TCP, stimulation (27, 28). Conceivably, dif- 
ferent binding to CD4 or CD8 may alter the activation and 
substrate  phosphorylation seen.  In addition,  the kinetics of 
p56  lck activation is critical,  since,  as the multiple  substrates 
move closer to p563ok at varying times, patterns ofphospho- 
rylation  and  signaling  may induce  specific  cellular  activa- 
tion. In the studies presented here, p56  kk is activated within 
1 rain ofT  cell:IEC coculture, which is much more rapid 
than  the  induction  of p56  l~k  by conventional  APCs  (e.g., 
monocytes). Interestingly, this activation is inhibited by an- 
tibodies to CD8, providing further evidence that the CD8 
molecule itself plays a critical role in this process. Lastly, the 
activation  of this  tyrosine  kinase  is  critical  for the  subse- 
quent  CD8 +  T  cell  proliferation,  since  treatment  of the 
cells with two different tyrosine kinase inhibitors (but not a 
PKC or PKA inhibitor) before coculture inhibits their abil- 
ity to proliferate. 
These  findings  are  especially  interesting  with  regard  to 
IEL. Several groups have reported that CD8 expressed on a 
major proportion  of IEL in  the  mouse  is  of the ot/o~ ho- 
modimeric form as opposed to the oe/]3 heterodimeric form 
seen in peripheral CD8 + T  cells (29, 30). Since p56  kk is as- 
sociated with  the CDSo~ chain,  it is intriguing to postulate 
that a double dose of p56  tck in cells  living adjacent to IECs 
(putatively bearing an activating ligand for such CD8 mol- 
ecules)  may account for the activated yet relatively anergic 
state of IELs described. 
However,  cross-linking  CD8  and  activation  of p56  kk 
alone  are  not sufficient for CD8 +  T  cell  proliferation.  In 
the absence ofIEC, anti-CD8 mAbs in the presence or ab- 
sence  of  cytokines  failed  to  promote  cell  proliferation. 
Therefore,  it appears that a second signal, possibly through 
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specific or alloreactive responses)  must  be  required.  Sup- 
port for such  a  possibility is provided by the finding that 
fyn, a TCR--associated kinase not activated by p56  lck, is also 
activated in T  cell:IEC cocultures (Fig. 7). 
Perhaps  the  most  compelling data underscoring the  di- 
chotomy between the peripheral and mucosal immune sys- 
tems comes from the studies using the routine T  cell hybri- 
domas transfected with genes either encoding human CD4 
or CD8et.  Monocytes predominantly stimulate p56  lck acti- 
vation in  CD4  transfectants, whereas  IEC stimulate p56  kk 
in CD8  transfectants. These findings suggest that, although 
IEC express class II molecules, these are either expressed at 
such a low level to prevent sufficient CD4  binding or, al- 
ternatively, as has been  suggested in  the  mouse,  they are 
aberrandy expressed (i.e., abnormal form)  (31)  and incapa- 
ble  of binding to  CD4  effectively. In  either  case,  such  a 
scenario compromises the interaction of IEC with CD4 + T 
cells  and  promotes  the  interaction  of IEC  with  CD8+T 
cells. 
The existence of suppressor T  cells has been controver- 
sial.  Direct activation of such  cells has been  fraught  with 
difficulties in vitro. Perhaps,  given the  nature  of the mu- 
cosal  immune  system,  the  gut  is  the  only  environment 
where suppression can be reproducibly induced. 
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